These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
459 related items for PubMed ID: 8380862
1. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism. Gullikson GW, Virina MA, Loeffler RF, Yang DC, Goldstin B, Wang SX, Moummi C, Flynn DL, Zabrowski DL. J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862 [Abstract] [Full Text] [Related]
2. Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists. Becker DP, Flynn DL, Moormann AE, Nosal R, Villamil CI, Loeffler R, Gullikson GW, Moummi C, Yang DC. J Med Chem; 2006 Feb 09; 49(3):1125-39. PubMed ID: 16451077 [Abstract] [Full Text] [Related]
3. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N, Hosoki K. J Pharmacol Exp Ther; 1997 Dec 09; 283(3):1000-8. PubMed ID: 9399969 [Abstract] [Full Text] [Related]
4. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors. de Ridder WJ, Schuurkes JA. J Pharmacol Exp Ther; 1993 Jan 09; 264(1):79-88. PubMed ID: 8093733 [Abstract] [Full Text] [Related]
5. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs. Mikami T, Ochi Y, Suzuki K, Saito T, Sugie Y, Sakakibara M. J Pharmacol Exp Ther; 2008 Apr 09; 325(1):190-9. PubMed ID: 18198343 [Abstract] [Full Text] [Related]
6. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats. Yamano M, Kamato T, Miyata K. Arzneimittelforschung; 1997 Nov 09; 47(11):1242-6. PubMed ID: 9428982 [Abstract] [Full Text] [Related]
7. SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae. Yang DC, Goldstin B, Moormann AE, Flynn DL, Gullikson GW. J Pharmacol Exp Ther; 1993 Sep 09; 266(3):1339-47. PubMed ID: 8396633 [Abstract] [Full Text] [Related]
8. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs. Gullikson GW, Loeffler RF, Viriña MA. J Pharmacol Exp Ther; 1991 Jul 01; 258(1):103-10. PubMed ID: 2072288 [Abstract] [Full Text] [Related]
9. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis. Linnik MD, Butler BT, Gaddis RR, Ahmed NK. J Pharmacol Exp Ther; 1991 Nov 01; 259(2):501-7. PubMed ID: 1941605 [Abstract] [Full Text] [Related]
10. Alpha 2-adrenergic model of gastroparesis: validation with renzapride, a stimulator of motility. Gullikson GW, Virina MA, Loeffler R, Erwin WD. Am J Physiol; 1991 Sep 01; 261(3 Pt 1):G426-32. PubMed ID: 1679600 [Abstract] [Full Text] [Related]
11. Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. Taniyama K, Nakayama S, Takeda K, Matsuyama S, Shirakawa J, Sano I, Tanaka C. J Pharmacol Exp Ther; 1991 Sep 01; 258(3):1098-104. PubMed ID: 1890614 [Abstract] [Full Text] [Related]
12. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. Yoshida N, Ito T, Karasawa T, Itoh Z. J Pharmacol Exp Ther; 1991 May 01; 257(2):781-7. PubMed ID: 2033519 [Abstract] [Full Text] [Related]
13. The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents. Fioramonti J, Dupuy C, Dupuy J, Bueno L. J Pharmacol Exp Ther; 1993 Sep 01; 266(3):1255-60. PubMed ID: 8371135 [Abstract] [Full Text] [Related]
14. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride. Matsunaga Y, Tanaka T, Yoshinaga K, Ueki S, Hori Y, Eta R, Kawabata Y, Yoshii K, Yoshida K, Matsumura T, Furuta S, Takei M, Tack J, Itoh Z. J Pharmacol Exp Ther; 2011 Mar 01; 336(3):791-800. PubMed ID: 21123674 [Abstract] [Full Text] [Related]
15. Prokinetic effects of a new 5-HT4 agonist, YKP10811, on gastric motility in dogs. Yin J, Xu X, Song G, Han HS, Kim HW, Chen JD. J Gastroenterol Hepatol; 2017 Mar 01; 32(3):625-630. PubMed ID: 27418395 [Abstract] [Full Text] [Related]
16. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Yoshida N, Omoya H, Kato S, Ito T. Arzneimittelforschung; 1993 Oct 01; 43(10):1078-83. PubMed ID: 8267674 [Abstract] [Full Text] [Related]
17. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Nagakura Y, Kamato T, Nishida A, Ito H, Yamano M, Miyata K. Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 01; 353(5):489-98. PubMed ID: 8740141 [Abstract] [Full Text] [Related]
18. Comparison between partial agonist (ME3412) and antagonist (alosetron) of 5-hydroxytryptamine 3 receptor on gastrointestinal function. Kawano K, Mori T, Fu L, Ito T, Niisato T, Yoshida S, Shiokawa S, Sato Y, Murakami H, Shishikura T. Neurogastroenterol Motil; 2005 Apr 01; 17(2):290-301. PubMed ID: 15787949 [Abstract] [Full Text] [Related]
19. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. Ueki S, Seiki M, Yoneta T, Aita H, Chaki K, Hori Y, Morita H, Tagashira E, Itoh Z. J Pharmacol Exp Ther; 1993 Jan 01; 264(1):152-7. PubMed ID: 8093722 [Abstract] [Full Text] [Related]